Nektar Therapeutics (NKTR) Change in Inventory (2010 - 2024)

Nektar Therapeutics' Change in Inventory history runs 15 years deep, the most recent figure standing at -$1.3 million for Q4 2024.

• On a quarterly basis, Change in Inventory fell 21.85% year-over-year to -$1.3 million in Q4 2024; TTM through Sep 2025 was -$1.3 million, a 396.2% decrease from a year earlier, with the FY2024 full-year figure at -$497000.0, up 28.9% from the prior year.
• Change in Inventory fell to -$1.3 million in Q4 2024 per NKTR's latest filing, from -$123000.0 in the prior quarter.
• Across five years, Change in Inventory topped out at $2.4 million in Q4 2020 and bottomed at -$2.4 million in Q3 2023.
• The 5-year median for Change in Inventory is $389500.0 (2020), against an average of $267050.0.
• Biggest YoY gain for Change in Inventory was 570.38% in 2023; the steepest drop was 838.62% in 2023.
• Year by year, Change in Inventory stood at $2.4 million in 2020, then plunged by 80.38% to $471000.0 in 2021, then slumped by 69.21% to $145000.0 in 2022, then sank by 838.62% to -$1.1 million in 2023, then slipped by 21.85% to -$1.3 million in 2024.
• Per Business Quant, the three latest NKTR Change in Inventory figures stand at -$1.3 million (Q4 2024), -$123000.0 (Q3 2024), and -$212000.0 (Q2 2024).